UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 839 - 848
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Albuminuria - prevention & control | Acute Kidney Injury - prevention & control | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - prevention & control | Glucagon-Like Peptide 1 - agonists | Liraglutide - adverse effects | Liraglutide - therapeutic use | Intention to Treat Analysis | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Care and treatment | Usage | Analysis | Diabetic nephropathies | Outcome and process assessment (Health Care) | Research | Liraglutide | Myocardial infarction | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Glucagon | Diabetes mellitus | Patients | Risk factors | Clinical outcomes | Glomerular filtration rate | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Drug therapy | Glucagon-like peptide 1 | Long-term effects | Kidney transplantation | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
The journal of high energy physics, ISSN 1126-6708, 11/2017, Volume 2017, Issue 11, pp. 1 - 55
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
no | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Medicin och hälsovetenskap
Journal Article
Physical review letters, ISSN 0031-9007, 04/2017, Volume 118, Issue 15, pp. 151801 - 151801
Journal Article
Physical review letters, ISSN 0031-9007, 2016, Volume 116, Issue 6, pp. 061102 - 061102
Physics, Multidisciplinary | Physical Sciences | Physics | Science & Technology | Intervals | Gravitational waves | Detectors | Waveforms | Luminosity | Texts | Black holes (astronomy) | Interferometers | General Relativity and Quantum Cosmology | Sciences of the Universe | Astrophysics | Cosmology and Extra-Galactic Astrophysics
Journal Article
Living reviews in relativity, ISSN 1433-8351, 2016, Volume 19, Issue 1, pp. 1 - 39
Journal Article